We are a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases. Bright Minds’ broad portfolio of new chemical entities (NCEs) are positioned to treat a variety of pain indications, seizures, and neuropsychiatric disorders.
Looking at the seriousness of the situation, experts at Bright Minds Biosciences have structured novel drugs sourced from mother nature. Our team of discovery scientists has been preparing better compounds of psychedelic drugs such as serotonin. These active compounds can help cure age-old problems such as depression, anxiety, MDD, Epilepsy, chronic pain, and many other neurological issues.
/image%2F6304363%2F20210225%2Fob_c47acc_clock-5701307-1280.jpg)
/image%2F6304363%2F20210222%2Fob_7ae4f0_man-4075279-1280.jpg)
/image%2F6304363%2F20210222%2Fob_66cb76_biotechnology-company-bright-minds.jpg)
/image%2F6304363%2F20210218%2Fob_315e03_drugdeveloper-brightminds.jpg)